Diabetes/metabolism research and reviewsHumansDiabetes MellitusType 2Sodium-Glucose Transporter 2 InhibitorsMale
Effect of SGLT2 Inhibitors + DPP-4 Inhibitors on Urine Microbiota in Type 2 Diabetes.
Marco Calvigioni, Edoardo Biancalana, Chiara Rossi, Diletta Mazzantini, Francesco Celandroni, Emilia Ghelardi, Anna Solini
Published: 202610.1002/dmrr.70127
Abstract
AIMS: A reduced compliance, due to urogenital minor infections, frequently compromises the clinical efficacy of SGLT2 inhibitors in subjects with type 2 diabetes (T2D). The combined use of SGLT2 inhibitors and dipeptidyl-peptidase four inhibitors see…
Preview only. Read the full abstract at the source